CTAs keep buying Treasuries, gold longs face stop-loss risk: BofA
In a challenging market environment, Olin Corporation (NYSE: OLN) stock has touched a 52-week low, reaching a price level of $24.48. According to InvestingPro analysis, the stock’s RSI indicates oversold conditions, while management has been actively buying back shares. This significant downturn reflects a broader trend for the company, which has seen its stock value decrease by 56.02% over the past year. Despite the decline, the company maintains a strong dividend history, having paid dividends for 52 consecutive years, with a current yield of 3.15%. Investors are closely monitoring Olin’s performance as it navigates through the current economic headwinds, with many keeping an eye on the company’s strategic moves to rebound from this low point. The 52-week low serves as a critical marker for Olin Corp (NYSE:OLN), as market participants consider the stock’s potential for recovery or further decline in the coming months. For deeper insights and additional ProTips about Olin’s valuation and future prospects, visit InvestingPro.
In other recent news, Olin Corporation has announced its 393rd consecutive quarterly dividend, underscoring its commitment to providing consistent returns to shareholders. The dividend of $0.20 per share is scheduled for March 14, 2025, for shareholders on record as of March 6, 2025. Meanwhile, several financial analysts have adjusted their outlooks on Olin, citing various challenges and expectations for the company’s financial performance. JPMorgan downgraded Olin’s stock from Overweight to Neutral and slashed the price target from $50 to $28, reflecting a conservative view on earnings potential, particularly due to pressures in the Winchester segment and higher production costs in the Chlor-alkali segment.
RBC Capital also downgraded the stock, moving it to Sector Perform with a reduced price target of $30, citing delayed demand recovery and tariff pressures. BMO Capital Markets maintained a Market Perform rating but lowered the price target to $34, acknowledging near-term earnings challenges due to seasonal fluctuations and soft consumer spending. KeyBanc Capital Markets, while reducing the price target to $40, retained an Overweight rating, noting concerns over weaker-than-expected first-quarter performance but highlighting Olin’s ability to maintain pricing in the chlor-alkali segment. These developments reflect a mix of cautious optimism and concern among analysts regarding Olin’s future earnings trajectory.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.